(3R,6R)-6-[(1S,3R,6S,8S,11S,12S,15R,16R)-6-hydroxy-12,16-dimethyl-15-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-methylheptane-2,3-diol
| Internal ID | a1562c2f-baaa-4e70-a6c3-7e861bdfb0f0 |
| Taxonomy | Lipids and lipid-like molecules > Steroids and steroid derivatives > Bile acids, alcohols and derivatives > Hydroxy bile acids, alcohols and derivatives > Trihydroxy bile acids, alcohols and derivatives |
| IUPAC Name | (3R,6R)-6-[(1S,3R,6S,8S,11S,12S,15R,16R)-6-hydroxy-12,16-dimethyl-15-pentacyclo[9.7.0.01,3.03,8.012,16]octadecanyl]-2-methylheptane-2,3-diol |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C28H48O3/c1-18(6-9-23(30)24(2,3)31)21-11-12-26(5)22-8-7-19-16-20(29)10-13-27(19)17-28(22,27)15-14-25(21,26)4/h18-23,29-31H,6-17H2,1-5H3/t18-,19+,20+,21-,22+,23-,25-,26+,27-,28+/m1/s1 |
| InChI Key | UAHRFUZWEZHJIW-YRIMGRIRSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C28H48O3 |
| Molecular Weight | 432.70 g/mol |
| Exact Mass | 432.36034539 g/mol |
| Topological Polar Surface Area (TPSA) | 60.70 Ų |
| XlogP | 6.50 |
| Atomic LogP (AlogP) | 5.70 |
| H-Bond Acceptor | 3 |
| H-Bond Donor | 3 |
| Rotatable Bonds | 5 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.9890 | 98.90% |
| Caco-2 | - | 0.5450 | 54.50% |
| Blood Brain Barrier | + | 0.7000 | 70.00% |
| Human oral bioavailability | + | 0.5286 | 52.86% |
| Subcellular localzation | Mitochondria | 0.6308 | 63.08% |
| OATP2B1 inhibitior | - | 0.5790 | 57.90% |
| OATP1B1 inhibitior | + | 0.8405 | 84.05% |
| OATP1B3 inhibitior | + | 0.9652 | 96.52% |
| MATE1 inhibitior | - | 1.0000 | 100.00% |
| OCT2 inhibitior | - | 0.8000 | 80.00% |
| BSEP inhibitior | - | 0.4587 | 45.87% |
| P-glycoprotein inhibitior | - | 0.6639 | 66.39% |
| P-glycoprotein substrate | + | 0.5169 | 51.69% |
| CYP3A4 substrate | + | 0.6667 | 66.67% |
| CYP2C9 substrate | + | 0.5963 | 59.63% |
| CYP2D6 substrate | - | 0.7274 | 72.74% |
| CYP3A4 inhibition | - | 0.8460 | 84.60% |
| CYP2C9 inhibition | - | 0.7327 | 73.27% |
| CYP2C19 inhibition | - | 0.7285 | 72.85% |
| CYP2D6 inhibition | - | 0.9609 | 96.09% |
| CYP1A2 inhibition | - | 0.7623 | 76.23% |
| CYP2C8 inhibition | - | 0.5902 | 59.02% |
| CYP inhibitory promiscuity | - | 0.9007 | 90.07% |
| UGT catelyzed | + | 0.8000 | 80.00% |
| Carcinogenicity (binary) | - | 0.8700 | 87.00% |
| Carcinogenicity (trinary) | Non-required | 0.7069 | 70.69% |
| Eye corrosion | - | 0.9887 | 98.87% |
| Eye irritation | - | 0.9334 | 93.34% |
| Skin irritation | - | 0.5196 | 51.96% |
| Skin corrosion | - | 0.9259 | 92.59% |
| Ames mutagenesis | - | 0.7100 | 71.00% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.6521 | 65.21% |
| Micronuclear | - | 0.9100 | 91.00% |
| Hepatotoxicity | - | 0.5808 | 58.08% |
| skin sensitisation | - | 0.6562 | 65.62% |
| Respiratory toxicity | + | 0.5889 | 58.89% |
| Reproductive toxicity | + | 0.9444 | 94.44% |
| Mitochondrial toxicity | + | 0.9000 | 90.00% |
| Nephrotoxicity | - | 0.7943 | 79.43% |
| Acute Oral Toxicity (c) | III | 0.5784 | 57.84% |
| Estrogen receptor binding | + | 0.8100 | 81.00% |
| Androgen receptor binding | + | 0.7366 | 73.66% |
| Thyroid receptor binding | + | 0.6311 | 63.11% |
| Glucocorticoid receptor binding | + | 0.8014 | 80.14% |
| Aromatase binding | + | 0.6882 | 68.82% |
| PPAR gamma | + | 0.5306 | 53.06% |
| Honey bee toxicity | - | 0.7366 | 73.66% |
| Biodegradation | - | 0.6250 | 62.50% |
| Crustacea aquatic toxicity | - | 0.5438 | 54.38% |
| Fish aquatic toxicity | + | 0.9662 | 96.62% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 98.92% | 97.25% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 94.75% | 91.11% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 93.63% | 96.09% |
| CHEMBL233 | P35372 | Mu opioid receptor | 93.51% | 97.93% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 92.76% | 92.86% |
| CHEMBL2996 | Q05655 | Protein kinase C delta | 92.39% | 97.79% |
| CHEMBL238 | Q01959 | Dopamine transporter | 90.43% | 95.88% |
| CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 90.10% | 95.58% |
| CHEMBL2179 | P04062 | Beta-glucocerebrosidase | 89.72% | 85.31% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 88.96% | 97.09% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 88.95% | 97.29% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 88.33% | 100.00% |
| CHEMBL2581 | P07339 | Cathepsin D | 87.81% | 98.95% |
| CHEMBL5888 | Q99558 | Mitogen-activated protein kinase kinase kinase 14 | 87.76% | 100.00% |
| CHEMBL4793 | Q86TI2 | Dipeptidyl peptidase IX | 87.16% | 96.95% |
| CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 86.85% | 96.61% |
| CHEMBL284 | P27487 | Dipeptidyl peptidase IV | 86.59% | 95.69% |
| CHEMBL5469 | Q14289 | Protein tyrosine kinase 2 beta | 86.42% | 91.03% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 86.39% | 98.05% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 85.78% | 100.00% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 85.04% | 92.88% |
| CHEMBL3746 | P80365 | 11-beta-hydroxysteroid dehydrogenase 2 | 84.80% | 94.78% |
| CHEMBL1937 | Q92769 | Histone deacetylase 2 | 84.70% | 94.75% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 84.30% | 94.45% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 84.11% | 98.10% |
| CHEMBL3837 | P07711 | Cathepsin L | 83.91% | 96.61% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 83.75% | 95.89% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 83.28% | 97.23% |
| CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 83.03% | 99.00% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 82.87% | 98.75% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 82.60% | 96.47% |
| CHEMBL1741186 | P51449 | Nuclear receptor ROR-gamma | 82.40% | 99.17% |
| CHEMBL3045 | P05771 | Protein kinase C beta | 82.38% | 97.63% |
| CHEMBL3492 | P49721 | Proteasome Macropain subunit | 82.37% | 90.24% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 82.24% | 93.56% |
| CHEMBL2035 | P08912 | Muscarinic acetylcholine receptor M5 | 81.72% | 94.62% |
| CHEMBL1994 | P08235 | Mineralocorticoid receptor | 81.54% | 100.00% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 81.27% | 100.00% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 81.08% | 82.69% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 81.03% | 97.14% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 80.87% | 95.27% |
| CHEMBL2959 | Q08881 | Tyrosine-protein kinase ITK/TSK | 80.60% | 95.00% |
| CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 | 80.48% | 89.34% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 80.23% | 90.08% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| Chukrasia tabularis |
| PubChem | 23655534 |
| LOTUS | LTS0106661 |
| wikiData | Q105268759 |